Recurrent infections are common features in patients affected by propionic acidaemia (McKusick 232000) and methylmalonic acidaemia (McKusick 251000). Since these disorders are biochemically characterized by tissue accumulation of propionic acid and methylmalonic acid respectively, it is possible that these compounds may act as immunosuppressants. We therefore investigated the effect of propionate and methylmalonate on cellular growth of human peripheral lymphocytes stimulated in vitro by phytohaemagglutinin, concanavalin A and pokeweed mitogen, a recognized test of cellular immunocompetence. Lymphocytes were cultured in flat-bottomed 96-well microplates at 37 mC for 96 h (phytohaemagglutinin and concanavalin A) or 144 h (pokeweed mitogen) in the presence of one mitogen at different concentrations and of one acid added at doses of 1.0, 2.5 or 5.0 mM. Cell blastogenesis was measured by the incorporation of tritiated thymidine into cellular DNA and compared with that of identical cultures with no acid added (controls). A consistent and progressive inhibitory effect of propionic acid with increasing concentrations in culture was identified with all mitogens and was more pronounced with pokeweed mitogen. Lymphocyte blastogenesis was not altered in the presence of methylmalonic acid. The effect of propionate was observed only when the drug was added at the beginning (phytohaemagglutinin-activated) or until 24 h (concanavalin A-and pokeweed mitogenactivated) of culture. The viability of lymphocytes after treatment with the drug, as assessed by the Trypan Blue exclusion test, revealed no change when compared with the same untreated lymphocytes, indicating no lymphocytotoxic activity. In conclusion, propionic acid, which accumulates in tissues of patients with propionic acidaemia, causes ' in vitro ' immunosuppression, which may be related to the recurrent infections characteristic of these patients.
Since these disorders are biochemically characterized by tissue accumulation of propionic acid and methylmalonic acid respectively, it is possible that these compounds may act as immunosuppressants. We therefore investigated the effect of propionate and methylmalonate on cellular growth of human peripheral lymphocytes stimulated in vitro by phytohaemagglutinin, concanavalin A and pokeweed mitogen, a recognized test of cellular immunocompetence. Lymphocytes were cultured in flat-bottomed 96-well microplates at 37 mC for 96 h (phytohaemagglutinin and concanavalin A) or 144 h (pokeweed mitogen) in the presence of one mitogen at different concentrations and of one acid added at doses of 1.0, 2.5 or 5.0 mM. Cell blastogenesis was measured by the incorporation of tritiated thymidine into cellular DNA and compared with that of identical cultures with no acid added (controls). A consistent and progressive inhibitory effect of propionic acid with increasing concentrations in culture was identified with all mitogens and was more pronounced with pokeweed mitogen. Lymphocyte blastogenesis was not altered in the presence of methylmalonic acid. The effect of propionate was observed only when the drug was added at the beginning (phytohaemagglutinin-activated) or until 24 h (concanavalin A-and pokeweed mitogenactivated) of culture. The viability of lymphocytes after treatment with the drug, as assessed by the Trypan Blue exclusion test, revealed no change when compared with the same untreated lymphocytes, indicating no lymphocytotoxic activity. In conclusion, propionic acid, which accumulates in tissues of patients with propionic acidaemia, causes ' in vitro ' immunosuppression, which may be related to the recurrent infections characteristic of these patients. [3] . Among the many clinical and biochemical symptoms common to the two disorders, recurrent infections and neutropenia are observed in children affected by propionic acidaemia and methylmalonic acidaemia [1, [3] [4] [5] . Patients with propionic acidaemia usually have respiratory tract or gastrointestinal infections, as well as a high frequency of skin lesions varying from nappy rash with Candida albicans infection to staphylococcal scalded skin syndrome, and some of them die of pneumonia and widespread infection [1, 5, 6] . Low resistance to infection may reflect immunosuppression and may be attributed to a variety of factors present in metabolic diseases such as malnutrition, acidosis and hypotonia. On the other hand, immunosuppressive activities have been found in a wide range of substances present in the serum of patients suffering from various pathologies [7] . Therefore, it is possible that the toxic metabolites which accumulate in propionic acidaemia and methylmalonic acidaemia may act as immunosuppressants. The present study was undertaken to investigate the effect of propionate and methylmalonate on cellular growth of human peripheral lymphocytes stimulated in vitro by phytohaemagglutinin (PHA), concanavalin A (Con A) and pokeweed mitogen (PWM), a well-recognized test of cellular immunocompetence, in order to identify the possible immunoregulatory properties of these compounds.
MATERIAL AND METHODS

Lymphocytes
Peripheral venous blood samples from healthy adults were collected into heparinized tubes. The plasma was separated and the lymphocytes isolated by the FicollHypaque gradient method [8] . The cells were removed from the interphase and, after washing three times with 5 % foetal calf serum (virus and mycoplasma screened, Gibco) in RPMI-1640 (with glutamine, Gibco), were centrifuged for 5 min at 400 g and finally suspended in RPMI-1640. The final concentration of the cell suspension was 2i10' cells\ml medium. Cell viability, determined by the Trypan Blue test, was always higher than 95 %.
Response to mitogens
The details of the procedure have been reported previously [9] . Briefly, flat-bottomed 96-well microtitre plates (Falcon) were prepared by adding 50 µl of cell suspension (10& cells), 60 µl of medium containing either PHA [final concentrations in culture 0.25 to 5.0 % (v\v), Difco], Con A (final concentrations in culture 12.5 to 125 µg\ml, Pharmacia) or PWM [final concentrations in culture 0.1 to 1.0 % (v\v), Wellcome], 40 µl of autologous plasma and 50 µl of RPMI-1640 medium (Gibco) containing either propionic acid or methylmalonic acid (Sigma Chemical Co.) at concentrations ranging from 1 to 5 mM. The total culture volume was 200 µl and 100 i.u.\ml penicillin and 100 µg\ml streptomycin were also added. Control cultures were prepared identically but with no organic acid supplementation. Organic acids were dissolved in RPMI-1640 medium on the same day of the experiment and the pH of the solutions was adjusted to 7.2-7.4 before addition to the cultures. The cultures were incubated in a humidified atmosphere of 5% CO # in air at 37 mC for 96 h (PHA and Con A) or 144 h (PWM). Twenty hours before harvest, 50 µl of medium containing 0.5 µCi of tritiated thymidine (TRA 306, Amersham, specific activity 2 Ci\mol) was added to each well. Cultures were harvested on glass fibre filters with a semi-automatic multiple harvester (PHD, Cambridge Technology Inc.). Cell-bound [$H]-thymidine was determined by counting in an LKB liquid scintillation counter. In some cultures, cell viability was measured at the end of the incubation period by the Trypan Blue dye exclusion test. Identical triplicate cultures were always performed and the median of each triplicate was used in the calculations. Results were expressed as c.p.m. or percentage of control cultures. Comparison between means of lymphocyte responsiveness was calculated for each acid by one-way ANOVA and by the Duncan multiple range test when the F probability was significant (P 0.05).
RESULTS
The effects of propionate and methylmalonate, added separately to cultures at concentrations of 1.0, 2.5 and 5.0 mM, on PHA-, Con A-and PWM-induced lymphocyte response were studied (Figures 1-3) . It can be seen that propionate inhibited lymphocyte proliferation whereas methylmalonate had no effect. Inhibition of PWM-stimulated lymphocytes was more accentuated than inhibition of lymphocytes treated with PHA or Con A. Increasing the concentration of the acid in culture provoked an additional inhibition of the rate of [$H]thymidine incorporation.
Next, we added 5 mM propionate at different times during incubation and compared the lymphocyte responses to the mitogens. The inhibitory action of Propionic acid and immunosuppression propionic acid occurred when the drug was added at the beginning of culture for PHA-stimulated lymphocytes or up to 24 h from the start of culture for cells stimulated with Con A and PWM (Figure 4) .
Cell viability determined at the end of cultures supplemented by 5 mM propionate or methylmalonate was similar to that of control cultures, reflecting no cytotoxic activity of the compounds tested (results not shown).
DISCUSSION
To our knowledge, little information is available in the literature about the effect of organic acids on the immune response. We previously reported that some acidic compounds accumulating in maple syrup urine disease have immunosuppressive properties [10] . The results presented in this paper demonstrate that propionic acid inhibits the transformation of human peripheral blood lymphocytes, as assessed by the incorporation of tritiated thymidine into cellular DNA. Our experimental system is generally accepted as one of the ' in vitro ' models of ' in vivo ' immune reaction [11] . Therefore, it is possible that the ' in vitro ' immunoregulatory activities detected here may reflect the situation in vivo.
The concentrations of propionate added to cultures (1.0, 2.5 and 5.0 mM) correspond to those encountered in the blood of patients suffering from propionic acidaemia. We believe that by cultivating human lymphocytes in The values are expressed as percentage of lymphocyte reactivity (meanspS.D., n l 4) of control cultures (100 % growth) where no acid was added. Differences between means of controls and the other groups were calculated by ANOVA followed by the Duncan multiple range test. Letters indicate significance between controls and the other groups. a, P 0.05 ; b, P 0.01. vitro in the presence of propionate, we mimicked the situation in vivo.
We found that [$H]thymidine incorporation into stimulated lymphocytes was reduced by 2.5 and 5.0 mM propionate in PHA-and Con A-treated cultures, whereas in PWM-activated cultures this inhibition was more pronounced, occurring with doses of 1.0 mM and above. The effect of propionate was dose dependent since increasing the concentration of the acid in culture resulted in an augmented suppression.
The immunosuppression identified in vitro was not fortuitous, since it occurred at various doses of the drugs and of the mitogens. It was not a non-specific inhibition due to an acidic compound either, because methylmalonate, a structurally similar molecule, did not have any effect. Finally, it cannot be attributed to cytotoxicity since at the highest concentration used (5 mM) the acid did not decrease cell viability, as assessed by the Trypan Blue exclusion test.
Previous investigators have shown that patients with propionic acidaemia present a high incidence of infections [5, 6] . Other authors observed ' in vivo ' immunosuppression in these patients [12, 13] . Muller et al. [12] found low serum IgG levels, leucopenia with lymphopenia and granulopenia, as well as depletion of Tand B-cells in lymph nodes from a child with propionic acidaemia. Lymphocytes from the patient responded well to various mitogens and antigens in the presence of 10 % AB serum, but the same lymphocytes and those from normal individuals failed to respond when the culture medium contained 10 % patients' serum. These results indicate the presence of one or more immunosuppressive factors in the serum of affected patients, rather than a lack of growth factors. Furthermore, patients' serum was not cytotoxic to lymphocytes since it did not decrease the viability of lymphocytes immersed in it for up to 72 h, as assessed by the Trypan Blue exclusion test. Similar findings were reported by Raby et al. [13] who described a patient with propionic acidaemia with low serum IgG and IgM levels, a normal proportion of T-cells and severe deficiency of peripheral B-cells.
The results reported in the present paper are in agreement with these studies and suggest that propionate may well be the suppressive factor or at least one of the immunosuppressants present in the serum of patients with propionic acidaemia.
In another report, it was verified that propionate strongly inhibits granulocyte\macrophage progenitor cell proliferation in marrow culture by approximately 100 % at concentrations of 3.2 mM, whereas methylmalonate had a mild inhibitory activity [14] . In addition, propionate did not reduce the viability of marrow cells in short-term cultures of 12-h duration. The authors propose that the neutropenia observed in patients with propionic acidaemia may be provoked by suppression of marrow neutrophil precursor proliferation by persistently high concentrations of the metabolite. They also suggest that neutropenia observed in patients with methylmalonic acidaemia may be a result of the concomitant increase of propionate or other proximal metabolites that occurs in this condition. Other investigators also found a clear dose-dependent propionate-mediated suppression of proliferation and maturation of haematopoietic progenitor cells and Tlymphocytic colony formation, and believe that the neutropenia, thrombopenia, anaemia and pancytopenia often observed during acute attacks in propionic acidaemia are due to increased tissue concentrations of propionate [15, 16] . Therefore, it is possible that the immunosuppressive properties of propionate in vivo may be due to a combination of its effects on haemopoiesis, causing neutropenia and lymphopenia, and on the lymphocyte response, as demonstrated in the present work, which may explain at least in part the increased rate of infections in patients with propionic acidaemia.
The molecular mechanism by which propionate inhibits lymphocyte proliferation is unknown, but could be caused by impairment of energy production due to the inhibition of various enzymes by the acid [17, 18] .
In conclusion, the present data describe a biological activity of propionate, suggesting that this compound has an inhibitory effect on lymphocyte proliferation. Although our results should be interpreted cautiously, the ' in vivo ' immunosuppressive activities already detected in some patients with propionic acidaemia strongly indicate that propionate is at least one of the factors responsible for such immunosuppression. Assessment of the reactivity of lymphocytes taken from patients with propionic acidaemia should also be a target for future studies in order to confirm our findings.
